Appointments
InSilicoTrials has appointed Dr Mark Lovern as chief platform officer of the firm which uses AI technology to accelerate the development of new drugs. With the digital transformation revolution reshaping various industries, the role of chief platform officer has become even more pivotal, InSilicoTrials said. Dr Lovern will combine his scientific knowledge of AI, machine [...]
Pheon Therapeutics, a UK company developing next generation antibody drug conjugates (ADCs) for hard-to-treat cancers, has appointed Arvin Yang, MD, PhD, as its chief medical officer. Dr Yang joins Pheon with over a decade of experience in leading therapeutic oncology products through early-stage clinical development and late-stage global registration trials at both Bristol Myers Squibb [...]
AI-powered, digital health platform HealthBook+, which empowers users to take ownership of their own health through guidance and early identification of conditions, has announced a new medical advisory board. The board brings together specialist clinicians with experience and expertise in a broad range of key fields including mental and behavioural health, paediatrics, concierge medicine, direct primary care, [...]
Biotech company AAX Biotech, specialising in innovative, patentable technologies for improving antibody-based medicines, has appointed Maria Lisa Knudsen as CEO. The appointment is expected to contribute to the company's growth and the development of its pioneering technologies. AAX Biotech is a Swedish startup biotech company aiming to solve unmet needs in developing next-generation antibody therapeutics. [...]
VivoSense, Inc. has announced the appointment of Colin Bower as CEO and a member of its Board of Directors. Bower will succeed Dudley Tabakin, who will continue with VivoSense as Chief Product Officer. VivoSense is an aend-to-end scientific solutions company developing novel digital endpoints from wearable sensor data. Bower said: “I’m delighted to join the [...]
Risk, quality and compliance software company, Radar Healthcare has appointed Rhian Bulmer into the newly created role of Chief Partnerships Officer. Bulmer has over 27 years of experience in health and social care, having held key positions at EMIS, Ramsay Healthcare and other health tech providers, arming her with experience across all elements of the [...]
Ergéa Group, the platform for cancer care, diagnostic imaging and medical technology services across Europe, has announced the appointment of two key positions in its senior team. Brendan Loughran joins the company as Head of Supplier Relationships, and Jason Long takes on the role of Head of International projects at Ergéa Group. Both appointments are [...]
Woebot Health has announced the appointment of Trina Histon, PhD, as Vice President of Clinical Product Strategy. The role will see Histon accelerate Woebot’s capabilities to integrate into care pathways and advance the software transformation of psychiatry, behavioural health and primary care. Histon’s experience in embedding and deploying digital health solutions in care delivery spans [...]
End-to-end medtech services provider ClariMed, Inc. has announced the appointment of Xin Zhang as the company's new Chief Financial Officer (CFO) and Head of Corporate Development. Zhang is an experienced company director and private equity investor in mid-market companies with a focus on long-term sustainable growth, change management and value creation. The new CFO brings [...]
ADC Therapeutics SA has announced the appointment of Jose “Pepe” Carmona as Chief Financial Officer (CFO), effective December 19, 2022. Carmona will serve on the company’s executive leadership team and succeeds Jenn Creel, who is leaving to pursue other opportunities. Carmona has over 20 years of leadership, commercial and partnership experience in the pharmaceutical industry, [...]
